Gene expression resulting from PrPC ablation and PrPC overexpression in murine and cellular models

Molecular Neurobiology

Volumn 49, Issue 1, 2014, Pages 413-423

  Llorens, Franc ^a,b   Ferrer, Isidre ^a,b,c   Del Río, José Antonio ^b,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Deep sequencing; Gene expression; Gene knockout; Microarrays; Neurodegeneration; Prion protein; RNA seq

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; CELL FUNCTION; GENE EXPRESSION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELLS, CULTURED; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, ANIMAL; PRION DISEASES; PRPC PROTEINS;

EID: 84894386861     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8529-0     Document Type: Review

References (110)

1. Kovacs GG, Budka H (2009) Molecular pathology of human prion diseases. Int J Mol Sci 10(3):976-999. doi: 10.3390/ijms10030976
2. Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect Biol 3(1):a006833. doi: 10.1101/cshperspect.a006833a006833
3. Aguzzi A, Baumann F, Bremer J (2008) The prion's elusive reason for being. Annu Rev Neurosci 31:439-477. doi: 10.1146/annurev.neuro.31.060407.125620
4. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279(5352):827-834
5. Tremblay P, Bouzamondo-Bernstein E, Heinrich C, Prusiner SB, DeArmond SJ (2007) Developmental expression of PrP in the post-implantation embryo. Brain Res 1139:60-67. doi: 10.1016/j.brainres.2006.12.055
6. Harris DA, Lele P, Snider WD (1993) Localization of the mRNA for a chicken prion protein by in situ hybridization. Proc Natl Acad Sci U S A 90(9):4309-4313
7. Ford MJ, Burton LJ, Morris RJ, Hall SM (2002) Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 113(1):177-192
8. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P (1999) Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A 96(7):4046-4051
9. Jeffrey M, Ryder S, Martin S, Hawkins SA, Terry L, Berthelin-Baker C, Bellworthy SJ (2001) Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 124(4):280-289. doi: 10.1053/jcpa.2001.0465
10. Hu W, Kieseier B, Frohman E, Eagar TN, Rosenberg RN, Hartung HP, Stuve O (2008) Prion proteins: physiological functions and role in neurological disorders. J Neurol Sci 264(1-2):1-8. doi: 10.1016/j.jns.2007.06.019
11. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR (2008) Physiology of the prion protein. Physiol Rev 88(2):673-728. doi: 10.1152/physrev.00007.2007
12. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15(6):1255-1264
13. Raeber AJ, Sailer A, Hegyi I, Klein MA, Rulicke T, Fischer M, Brandner S, Aguzzi A, Weissmann C (1999) Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci U S A 96(7):3987-3992
14. Mallucci GR (2009) Prion neurodegeneration: starts and stops at the synapse. Prion 3(4):195-201
15. Jouvin-Marche E, Attuil-Audenis V, Aude-Garcia C, Rachidi W, Zabel M, Podevin-Dimster V, Siret C, Huber C, Martinic M, Riondel J, Villiers CL, Favier A, Naquet P, Cesbron JY, Marche PN (2006) Overexpression of cellular prion protein induces an antioxidant environment altering T cell development in the thymus. J Immunol 176(6):3490-3497
16. Coulpier M, Messiaen S, Boucreaux D, Eloit M (2006) Axotomy-induced motoneuron death is delayed in mice overexpressing PrPc. Neuroscience 141(4):1827-1834. doi: 10.1016/j.neuroscience.2006.05.037
17. Rangel A, Madronal N, Gruart A, Gavin R, Llorens F, Sumoy L, Torres JM, Delgado-Garcia JM, Del Rio JA (2009) Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PLoS One 4(10):e7592. doi: 10.1371/journal.pone.0007592
18. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang SL, Torchia M, Carlson GA, Prusiner SB (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76(1):117-129
19. Rial D, Duarte FS, Xikota JC, Schmitz AE, Dafre AL, Figueiredo CP, Walz R, Prediger RD (2009) Cellular prion protein modulates age-related behavioral and neurochemical alterations in mice. Neuroscience 164(3):896-907. doi: 10.1016/j.neuroscience.2009.09.005
20. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356(6370):577-582. doi: 10.1038/356577a0
21. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8(2-3):121-127
22. Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y, Mastrangelo P, Wang K, Smit AF, Katamine S, Carlson GA, Cohen FE, Prusiner SB, Melton DW, Tremblay P, Hood LE, Westaway D (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 292(4):797-817
23. Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, Aguzzi A, Weissmann C (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J 20(4):694-702
24. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380(6574):528-531
25. Weissmann C, Aguzzi A (1999) Perspectives: neurobiology. PrP's double causes trouble. Science 286(5441):914-915
26. Steele AD, Lindquist S, Aguzzi A (2007) The prion protein knockout mouse: a phenotype under challenge. Prion 1(2):83-93
27. Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43-60
28. Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, Frigg R, Roeckl C, Fischer MB, Weissmann C, Aguzzi A (1998) Transgenic and knockout mice in research on prion diseases. Brain Pathol 8(4):715-733
29. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73(7):1339-1347
30. Sailer A, Bueler H, Fischer M, Aguzzi A, Weissmann C (1994) No propagation of prions in mice devoid of PrP. Cell 77(7):967-968
31. Sakaguchi S, Katamine S, Shigematsu K, Nakatani A, Moriuchi R, Nishida N, Kurokawa K, Nakaoke R, Sato H, Jishage K et al (1995) Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent. J Virol 69(12):7586-7592
32. Richt JA, Kasinathan P, Hamir AN, Castilla J, Sathiyaseelan T, Vargas F, Sathiyaseelan J, Wu H, Matsushita H, Koster J, Kato S, Ishida I, Soto C, Robl JM, Kuroiwa Y (2007) Production of cattle lacking prion protein. Nat Biotechnol 25(1):132-138. doi: 10.1038/nbt1271
33. Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J (1992) The prion protein gene: a role in mouse embryogenesis? Development 115(1):117-122
34. Miele G, Alejo Blanco AR, Baybutt H, Horvat S, Manson J, Clinton M (2003) Embryonic activation and developmental expression of the murine prion protein gene. Gene Expr 11(1):1-12
35. Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21(3):202-210
36. Nowak MA, Boerlijst MC, Cooke J, Smith JM (1997) Evolution of genetic redundancy. Nature 388(6638):167-171. doi: 10.1038/40618
37. Watts JC, Westaway D (2007) The prion protein family: diversity, rivalry, and dysfunction. Biochim Biophys Acta 1772(6):654-672
38. Paisley D, Banks S, Selfridge J, McLennan NF, Ritchie AM, McEwan C, Irvine DS, Saunders PT, Manson JC, Melton DW (2004) Male infertility and DNA damage in Doppel knockout and prion protein/Doppel double-knockout mice. Am J Pathol 164(6):2279-2288. doi: 10.1016/S0002-9440(10)63784-4
39. C-deficiency. Proc Natl Acad Sci U S A 109(23):9035-9040. doi: 10.1073/pnas.1202130109
40. Young R, Passet B, Vilotte M, Cribiu EP, Beringue V, Le Provost F, Laude H, Vilotte JL (2009) The prion or the related Shadoo protein is required for early mouse embryogenesis. FEBS Lett 583(19):3296-3300. doi: 10.1016/j.febslet.2009.09.027
41. Beck JA, Campbell TA, Adamson G, Poulter M, Uphill JB, Molou E, Collinge J, Mead S (2008) Association of a null allele of SPRN with variant Creutzfeldt-Jakob disease. J Med Genet 45(12):813-817. doi: 10.1136/jmg.2008. 061804
42. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, Manson JC (1996) Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380(6575):639-642. doi: 10.1038/380639a0
43. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG (1994) Prion protein is necessary for normal synaptic function. Nature 370(6487):295-297
44. C controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J Neurosci 33(7):2973-2983. doi: 10.1523/JNEUROSCI.4149-12.2013
45. Lobao-Soares B, Walz R, Prediger RD, Freitas RL, Calvo F, Bianchin MM, Leite JP, Landemberger MC, Coimbra NC (2008) Cellular prion protein modulates defensive attention and innate fear-induced behaviour evoked in transgenic mice submitted to an agonistic encounter with the tropical coral snake Oxyrhopus guibei. Behav Brain Res 194(2):129-137. doi: 10.1016/j.bbr.2008.06.006
46. Gadotti VM, Bonfield SP, Zamponi GW (2012) Depressive-like behaviour of mice lacking cellular prion protein. Behav Brain Res 227(2):319-323. doi: 10.1016/j.bbr.2011.03.012
47. Lobao-Soares B, Walz R, Carlotti CG Jr, Sakamoto AC, Calvo F, Terzian AL, da Silva JA, Wichert-Ana L, Coimbra NC, Bianchin MM (2007) Cellular prion protein regulates the motor behaviour performance and anxiety-induced responses in genetically modified mice. Behav Brain Res 183(1):87-94. doi: 10.1016/j.bbr.2007.05.027
48. Singh A, Mohan ML, Isaac AO, Luo X, Petrak J, Vyoral D, Singh N (2009) Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis. PLoS One 4(2):e4468. doi: 10.1371/journal.pone. 0004468
49. Strom A, Wang GS, Scott FW (2011) Impaired glucose tolerance in mice lacking cellular prion protein. Pancreas 40(2):229-232
50. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13(3):310-318. doi: 10.1038/nn.2483
51. C against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell 22(17):3041-3054. doi: 10.1091/mbc.E11-04-0321
52. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, Zamponi GW (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 181(3):551-565. doi: 10.1083/jcb.200711002
53. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21(13):3307-3316. doi: 10.1093/emboj/cdf325
54. Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA (2007) Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J Neurosci Res 85(12):2741-2755. doi: 10.1002/jnr.21215
55. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuroprotective signals. EMBO J 21(13):3317-3326. doi: 10.1093/emboj/cdf324
56. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40(12):1679-1682
57. Fleisch VC, Leighton PL, Wang H, Pillay LM, Ritzel RG, Bhinder G, Roy B, Tierney KB, Ali DW, Waskiewicz AJ, Allison WT (2013) Targeted mutation of the gene encoding prion protein in zebrafish reveals a conserved role in neuron excitability. Neurobiol Dis 55:11-25. doi: 10.1016/j.nbd.2013.03.007
58. Llorens F, Del Rio JA (2012) Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity. Prion 6(3):245-51
59. Brown DR, Nicholas RS, Canevari L (2002) Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67(2):211-224
60. Aude-Garcia C, Villiers C, Candeias SM, Garrel C, Bertrand C, Collin V, Marche PN, Jouvin-Marche E (2011) Enhanced susceptibility of T lymphocytes to oxidative stress in the absence of the cellular prion protein. Cell Mol Life Sci 68(4):687-696. doi: 10.1007/s00018-010-0477-5
61. Satoh J, Yamamura T (2004) Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol 24(6):793-814
62. Loubet D, Dakowski C, Pietri M, Pradines E, Bernard S, Callebert J, Ardila-Osorio H, Mouillet-Richard S, Launay JM, Kellermann O, Schneider B (2012) Neuritogenesis: the prion protein controls beta1 integrin signaling activity. FASEB J 26(2):678-690. doi: 10.1096/fj.11-185579
63. Liang J, Pan Y, Zhang D, Guo C, Shi Y, Wang J, Chen Y, Wang X, Liu J, Guo X, Chen Z, Qiao T, Fan D (2007) Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J 21(9):2247-2256. doi: 10.1096/fj.06-7799com
64. Llorens F, Carulla P, Villa A, Torres JM, Fortes P, Ferrer I, Del Rio JA (2013) PrP regulates EGFR function and cell shape dynamics in Neuro2a cells. J Neurochem. doi: 10.1111/jnc.12283
65. Miranda A, Pericuesta E, Ramirez MA, Gutierrez-Adan A (2011) Prion protein expression regulates embryonic stem cell pluripotency and differentiation. PLoS One 6(4):e18422. doi: 10.1371/journal.pone.0018422
66. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Yokoyama T, Itohara S, Onodera T (1999) Prions prevent neuronal cell-line death. Nature 400(6741):225-226. doi: 10.1038/22241
67. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G, Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 97(1):145-150
68. Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD (2006) Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A 103(9):3416-3421. doi: 10.1073/pnas.0511290103
69. Fujisawa M, Kanai Y, Nam SY, Maeda S, Nakamuta N, Kano K, Kurohmaru M, Hayashi Y (2004) Expression of Prnp mRNA (prion protein gene) in mouse spermatogenic cells. J Reprod Dev 50(5):565-570
70. Kim BH, Kim JI, Choi EK, Carp RI, Kim YS (2005) A neuronal cell line that does not express either prion or doppel proteins. Neuroreport 16(5):425-429
71. Bribian A, Fontana X, Llorens F, Gavin R, Reina M, Garcia-Verdugo JM, Torres JM, de Castro F, del Rio JA (2012) Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS. PLoS One 7(4):e33872. doi: 10.1371/journal.pone. 0033872
72. Santos TG, Silva IR, Costa-Silva B, Lepique AP, Martins VR, Lopes MH (2011) Enhanced neural progenitor/stem cells self-renewal via the interaction of stress-inducible protein 1 with the prion protein. Stem Cells 29(7):1126-1136. doi: 10.1002/stem.664
73. Erlich RB, Kahn SA, Lima FR, Muras AG, Martins RA, Linden R, Chiarini LB, Martins VR, Moura Neto V (2007) STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55(16):1690-1698. doi: 10.1002/glia.20579
74. Cheng Y, Tao L, Xu J, Li Q, Yu J, Jin Y, Chen Q, Xu Z, Zou Q, Liu X (2013) CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients. Mol Carcinog. doi: 10.1002/mc.22021
75. C modifies cell structure and cell cycle regulation. FEBS Lett 580(17):4097-4104. doi: 10.1016/j.febslet.2006.06.054
76. Basu U, Guan le L, Moore SS (2012) Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases. Curr Genomics 13(5):369-378. doi: 10.2174/138920212801619223
77. Benvegnù S, Roncaglia P, Agostini F, Casalone C, Corona C, Gustincich S, Legname G (2011) Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus. Physiol Genomics 43(12):711-725. doi: 10.1152/physiolgenomics.00205.2010
78. Bodrikov V, Solis GP, Stuermer CA (2011) Prion protein promotes growth cone development through reggie/flotillin-dependent N-cadherin trafficking. J Neurosci 31(49):18013-18025. doi: 10.1523/JNEUROSCI.4729-11.2011
79. Nieznanska H, Dudek E, Zajkowski T, Szczesna E, Kasprzak AA, Nieznanski K (2012) Prion protein impairs kinesin-driven transport. Biochem Biophys Res Commun 425(4):788-793. doi: 10.1016/j.bbrc.2012.07.153
80. Osiecka KM, Nieznanska H, Skowronek KJ, Jozwiak J, Nieznanski K (2011) Tau inhibits tubulin oligomerization induced by prion protein. Biochim Biophys Acta 1813(10):1845-1853. doi: 10.1016/j.bbamcr.2011.06.016
81. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V, Defamie V, Dessen P, Williams G, Lyons P, Rios G, Mari B, Gulari E, Kastner P, Gidrol X, Freeman TC, Barbry P (2006) An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res 34(12):e87. doi: 10.1093/nar/gkl485
82. Chadi S, Young R, Le Guillou S, Tilly G, Bitton F, Martin-Magniette ML, Soubigou-Taconnat L, Balzergue S, Vilotte M, Peyre C, Passet B, Beringue V, Renou JP, Le Provost F, Laude H, Vilotte JL (2010) Brain transcriptional stability upon prion protein-encoding gene invalidation in zygotic or adult mouse. BMC Genomics 11:448. doi: 10.1186/1471-2164-11-448
83. Hooper NM, Taylor DR, Watt NT (2008) Mechanism of the metal-mediated endocytosis of the prion protein. Biochem Soc Trans 36(Pt 6):1272-1276. doi: 10.1042/BST0361272
84. Caetano FA, Lopes MH, Hajj GN, Machado CF, Pinto Arantes C, Magalhaes AC, Vieira Mde P, Americo TA, Massensini AR, Priola SA, Vorberg I, Gomez MV, Linden R, Prado VF, Martins VR, Prado MA (2008) Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci 28(26):6691-6702. doi: 10.1523/JNEUROSCI.1701-08.2008
85. Laine J, Marc ME, Sy MS, Axelrad H (2001) Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur J Neurosci 14(1):47-56
86. Bailly Y, Haeberle AM, Blanquet-Grossard F, Chasserot-Golaz S, Grant N, Schulze T, Bombarde G, Grassi J, Cesbron JY, Lemaire-Vieille C (2004) Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain. J Comp Neurol 473(2):244-269. doi: 10.1002/cne.20117
87. Mironov A Jr, Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ (2003) Cytosolic prion protein in neurons. J Neurosci 23(18):7183-7193
88. Malaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CA (2009) Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 7(3):e55. doi: 10.1371/journal.pbio.1000055
89. Ozsolak F, Milos PM (2011) RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 12(2):87-98. doi: 10.1038/nrg2934
90. Khalifé M, Young R, Passet B, Halliez S, Vilotte M, Jaffrezic F, Marthey S, Beringue V, Vaiman D, Le Provost F, Laude H, Vilotte JL (2011) Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis. PLoS One 6(8):e23253. doi: 10.1371/journal.pone.0023253
91. Nourizadeh-Lillabadi R, Seilo Torgersen J, Vestrheim O, Konig M, Alestrom P, Syed M (2010) Early embryonic gene expression profiling of zebrafish prion protein (Prp2) morphants. PLoS One 5(10):e13573. doi: 10.1371/journal.pone. 0013573
92. Satoh J, Kuroda Y, Katamine S (2000) Gene expression profile in prion protein-deficient fibroblasts in culture. Am J Pathol 157(1):59-68
93. Li S, Wilkinson M, Xia X, David M, Xu L, Purkel-Sutton A, Bhardwaj A (2005) Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. Mol Ther 11(1):112-119. doi: 10.1016/j.ymthe.2004.09.008
94. Liang J, Luo G, Ning X, Shi Y, Zhai H, Sun S, Jin H, Liu Z, Zhang F, Lu Y, Zhao Y, Chen X, Zhang H, Guo X, Wu K, Fan D (2007) Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol 85(3):375-383. doi: 10.1139/o07-052
95. 2+ movements in cerebellar granule neurons. J Neurochem 116(5):881-890. doi: 10.1111/j.1471-4159.2010.07015.x
96. C). FEBS Lett 583(2):389-393. doi: 10.1016/j.febslet.2008.12.038
97. Li C, Yu S, Nakamura F, Yin S, Xu J, Petrolla AA, Singh N, Tartakoff A, Abbott DW, Xin W, Sy MS (2009) Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J Clin Invest 119(9):2725-2736. doi: 10.1172/JCI39542
98. de Wit M, Jimenez CR, Carvalho B, Belien JA, Delis-van Diemen PM, Mongera S, Piersma SR, Vikas M, Navani S, Ponten F, Meijer GA, Fijneman RJ (2012) Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut 61(6):855-864. doi: 10.1136/gutjnl-2011-300511
99. +/+ mice. Neuroreport 19(10):1027-1031. doi: 10.1097/WNR.0b013e3283046157
100. Stella R, Cifani P, Peggion C, Hansson K, Lazzari C, Bendz M, Levander F, Sorgato MC, Bertoli A, James P (2012) Relative quantification of membrane proteins in wild-type and prion protein (PrP)-knockout cerebellar granule neurons. J Proteome Res 11(2):523-536. doi: 10.1021/pr200759m
101. Cloonan N, Grimmond SM (2008) Transcriptome content and dynamics at single-nucleotide resolution. Genome Biol 9(9):234. doi: 10.1186/gb-2008-9-9-234
102. Llorens F, Hummel M, Pastor X, Ferrer A, Pluvinet R, Vivancos A, Castillo E, Iraola S, Mosquera AM, Gonzalez E, Lozano J, Ingham M, Dohm JC, Noguera M, Kofler R, del Rio JA, Bayes M, Himmelbauer H, Sumoy L (2011) Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysis. BMC Genomics 12:326. doi: 10.1186/1471-2164-12-326
103. Bottomly D, Walter NA, Hunter JE, Darakjian P, Kawane S, Buck KJ, Searles RP, Mooney M, McWeeney SK, Hitzemann R (2011) Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-seq and microarrays. PLoS One 6(3):e17820. doi: 10.1371/journal.pone.0017820
104. Llorens F, Hummel M, Pantano L, Pastor X, Vivancos A, Castillo E, Mattlin H, Ferrer A, Ingham M, Noguera M, Kofler R, Dohm JC, Pluvinet R, Bayes M, Himmelbauer H, Del Rio JA, Marti E, Sumoy L (2013) Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor. BMC Genomics 14:371. doi: 10.1186/1471-2164-14-371
105. Choi HJ, Kang KS, Fukui M, Zhu BT (2011) Critical role of the JNK-p53-GADD45alpha apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons. Br J Pharmacol 162(1):175-192. doi: 10.1111/j.1476-5381. 2010.01041.x
106. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9(10):1274-1281
107. Junn E, Mouradian MM (2012) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133(2):142-150. doi: 10.1016/j.pharmthera.2011.10.002
108. Abe M, Bonini NM (2013) MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol 23(1):30-36. doi: 10.1016/j.tcb.2012.08.013
109. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3(11):e3652. doi: 10.1371/journal.pone.0003652
110. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20(5):515-524. doi: 10.1101/gad.1399806